← Holders
Tetragon Partners GP Ltd
What Tetragon Partners GP Ltd reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1515070 · Filed Nov 16, 2026
- Positions
- 37
- Reported value
- $766M
- Opened
- 6
- Closed
- 8
- Other managers included
- 3
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$747.6M44 positions
- Dec 31, 2025$474.3M28 positions
- Mar 31, 2026$515.1M36 positions
- Jun 30, 2026$635.1M39 positions
- Sep 30, 2026$766M37 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PATHUiPath, Inc. | 32.5M | +5.0% | $417.3M | 54.5% |
KGEIKolibri Global Energy Inc. | 6.8M | ±0% | $42.3M | 5.5% |
SLNSilence Therapeutics plc | 2.4M | +218.7% | $26.6M | 3.5% |
PHVSPharvaris N.V. | 838.2K | +183.5% | $26.6M | 3.5% |
IONSIonis Pharmaceuticals Inc | 440.9K | +353.8% | $19.7M | 2.6% |
AUTLAutolus Therapeutics plc | 9.5M | ±0% | $18.4M | 2.4% |
ARWRArrowhead Pharmaceuticals, Inc. | 264K | +102.4% | $17.3M | 2.3% |
LYFTLyft, Inc. | 1M | ±0% | $15M | 2% |
WKWorkiva Inc | 225K | −10.0% | $15M | 2% |
MBXMBX Biosciences, Inc. | 220.6K | +8.4% | $12.9M | 1.7% |
DFTXDefinium Therapeutics, Inc. | 310.9K | +8.3% | $11.8M | 1.5% |
CXMSprinklr, Inc. | 2.2M | ±0% | $10.9M | 1.4% |
CLDXCelldex Therapeutics, Inc. | 295.9K | +1.9% | $9.6M | 1.3% |
IMVTImmunovant, Inc. | 275.2K | +7.5% | $9.3M | 1.2% |
HRMYHarmony Biosciences Holdings, Inc. | 226.7K | +12.8% | $8.9M | 1.2% |
ALKTAlkami Technology, Inc. | 650K | +8.3% | $8.9M | 1.2% |
ALKSAlkermes plc. | 206.8K | +8.8% | $8.4M | 1.1% |
DYNDyne Therapeutics, Inc. | 511.3K | +43.4% | $8.2M | 1.1% |
RLAYRelay Therapeutics, Inc. | 447.2K | −21.6% | $8.1M | 1.1% |
AGIOAgios Pharmaceuticals, Inc. | 215.5K | +4.8% | $7.2M | 0.9% |
CELCCelcuity Inc. | 87.4K | +36.4% | $7M | 0.9% |
NBIXNeurocrine Biosciences Inc | 47K | New | $6.7M | 0.9% |
KRYSKrystal Biotech, Inc. | 19.7K | ±0% | $6.5M | 0.9% |
AXSMAxsome Therapeutics, Inc. | 35K | New | $6.5M | 0.8% |
WBDWarner Bros. Discovery, Inc. | 200K | −20.0% | $6.2M | 0.8% |
NKTRNektar Therapeutics | 101.6K | +16.8% | $6.2M | 0.8% |
| 500K | +66.7% | $5.5M | 0.7% | |
UBERUber Technologies, Inc | 71.4K | New | $4.9M | 0.6% |
SNOWSnowflake Inc. | 10K | ±0% | $3.4M | 0.4% |
ANTXAN2 Therapeutics, Inc. | 603.4K | New | $3.2M | 0.4% |
ANNXAnnexon, Inc. | 655.9K | −47.2% | $2.8M | 0.4% |
| 50K | ±0% | $1.7M | 0.2% | |
| 100K | New | $1.2M | 0.2% | |
GLUEMonte Rosa Therapeutics, Inc. | 56.1K | ±0% | $668.7K | 0.1% |
TECXTectonic Therapeutic, Inc. | 26.8K | −42.4% | $624.1K | 0.1% |
SLGLSol-Gel Technologies Ltd. | 8.3K | New | $617K | 0.1% |
| 75.1K | ±0% | $141.9K | 0.1% |